David Denning, FRCP FRCPath DCH FMedSci

Search results

• Defining global antifungal azole resistance in Aspergillus – enhancing diagnostics and driving drug discovery

  Denning, D. (Participant), (Participant), Bromley, M. (Participant), Bowyer, P. (Participant) & Moore, C. (Participant)

  Impact: Health and wellbeing, Policy, Economic

• Diagnostics and novel life-saving therapies for aspergillosis

  Denning, D. (Participant), Anderson, M. J. (Participant), Moore, C. (Participant), (Participant), Bowyer, P. (Participant), Bromley, M. (Participant), Smith, N. (Participant), (Participant) & (Participant)

  Impact: Health impacts

• Successfully tackling serious fungal diseases to transform global population health

  Denning, D. (Participant), Richardson, M. (Participant) & Gago, S. (Participant)

  Impact: Health and wellbeing

• Transforming patient outcome of pulmonary aspergillosis with better and faster diagnosis and therapy

  Denning, D. (Participant), (Participant) & Felton, T. (Participant)

  Impact: Health and wellbeing, Economic